-
Je něco špatně v tomto záznamu ?
Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains
M. Krátký, J. Vinšová, J. Stolaříková,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT13346
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- antituberkulotika farmakologie toxicita MeSH
- benzoáty farmakologie toxicita MeSH
- buňky Hep G2 MeSH
- inhibiční koncentrace 50 MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- mnohočetná bakteriální léková rezistence MeSH
- Mycobacterium avium účinky léků MeSH
- Mycobacterium kansasii účinky léků MeSH
- Mycobacterium tuberculosis účinky léků MeSH
- salicylanilidy farmakologie toxicita MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The increasing emergence especially of drug-resistant tuberculosis has led to a strong demand for new anti-tuberculosis drugs. Eighteen salicylanilide benzoates were evaluated for their inhibition potential against Mycobacterium tuberculosis, Mycobacterium avium and two strains of Mycobacterium kansasii; minimum inhibitory concentration values ranged from 0.5 to 16 μmol/L. The most active esters underwent additional biological assays. Four benzoates inhibited effectively the growth of five multidrug-resistant strains and one extensively drug-resistant strain of M. tuberculosis at low concentrations (0.25–2 μmol/L) regardless of the resistance patterns. The highest rate of multidrug-resistant mycobacteria inhibition expressed 4-chloro-2-[4-(trifluoromethyl)-phenylcarbamoyl]phenyl benzoate (0.25–1 μmol/L). Unfortunately, the most potent esters were still considerably cytotoxic, although mostly less than their parent salicylanilides.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024196
- 003
- CZ-PrNML
- 005
- 20181212111356.0
- 007
- ta
- 008
- 130703s2012 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules171112812 $2 doi
- 035 __
- $a (PubMed)23114617
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Krátký, Martin $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové 50005, Czech Republic. martin.kratky@faf.cuni.cz $7 jo2017947786
- 245 10
- $a Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains / $c M. Krátký, J. Vinšová, J. Stolaříková,
- 520 9_
- $a The increasing emergence especially of drug-resistant tuberculosis has led to a strong demand for new anti-tuberculosis drugs. Eighteen salicylanilide benzoates were evaluated for their inhibition potential against Mycobacterium tuberculosis, Mycobacterium avium and two strains of Mycobacterium kansasii; minimum inhibitory concentration values ranged from 0.5 to 16 μmol/L. The most active esters underwent additional biological assays. Four benzoates inhibited effectively the growth of five multidrug-resistant strains and one extensively drug-resistant strain of M. tuberculosis at low concentrations (0.25–2 μmol/L) regardless of the resistance patterns. The highest rate of multidrug-resistant mycobacteria inhibition expressed 4-chloro-2-[4-(trifluoromethyl)-phenylcarbamoyl]phenyl benzoate (0.25–1 μmol/L). Unfortunately, the most potent esters were still considerably cytotoxic, although mostly less than their parent salicylanilides.
- 650 _2
- $a antituberkulotika $x farmakologie $x toxicita $7 D000995
- 650 _2
- $a benzoáty $x farmakologie $x toxicita $7 D001565
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a mnohočetná bakteriální léková rezistence $7 D024901
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a Mycobacterium avium $x účinky léků $7 D009162
- 650 _2
- $a Mycobacterium kansasii $x účinky léků $7 D019909
- 650 _2
- $a Mycobacterium tuberculosis $x účinky léků $7 D009169
- 650 _2
- $a salicylanilidy $x farmakologie $x toxicita $7 D012458
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vinšová, Jarmila, $u - $d 1951- $7 nlk19990073991
- 700 1_
- $a Stolaříková, Jiřina $u - $7 xx0142458
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 17, č. 11 (2012), s. 12812-12820
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23114617 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20181212111520 $b ABA008
- 999 __
- $a ok $b bmc $g 987876 $s 822576
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 17 $c 11 $d 12812-12820 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a NT13346 $p MZ0
- LZP __
- $a Pubmed-20130703